The relationship between plasma molybdenum (Mo) and dietary intake has not been investigated in humans. We developed an isotope dilution method to determine molybdenum in 0.5 mL blood plasma by ICP-MS and conducted a study to determine the effect of dietary intake on plasma molybdenum. Twelve young men consumed a very low Mo diet (22 μg/day) for 24 days while confined to the WHNRC metabolic research unit and plasma molybdenum was monitored. 97Mo was infused in four of the subjects (Group 1) to follow its clearance from the blood. The other eight remained in unit for 120 days (an additional 96 days). Four consumed the 22 μg/day molybdenum diet for 102 days followed by 467 μg/day for 18 days (Group 2). and four consumed five levels of dietary molybdenum for 24 days each (Group 3). 100Mo was added to the diet one or more times at each dietary level. Total plasma molybdenum and 100Mo were monitored throughout the study. Plasma molybdenum in the 12 subjects decreased from 8.2 ± 0.5 to 6.1 ± 0.5 nmol/L after 13 days of low molybdenum intake and was 5.1 ± 0.5 nmol/L after 24 days. In Group 2, average plasma molybdenum was 7.8 ± 0.9 nmol/L at the beginning of the study, 5.4 ± 0.4 nmol/L during the 102 days low molybdenum period, and 16.5 ± 0.6 nmol/L during the high molybdenum period. Plasma molybdenum in Group 3 was 4.2 ± 2.1 nmol/L at 22 μg/day; 5.8 ± 2.5 nmol/L at 72 μg/day; 6.6 ± 2.3 nmol/L at 121 μg/day; 19.7 nmol/L ±2.1 at 467 μg/day; and 43.9 ± 2.1 nmol/L at 1490 μg/day. The results demonstrate that, in contrast to most other essential minerals, plasma molybdenum reflects low and high dietary molybdenum intakes within 14 days and may a useful indicator of low and high dietary intakes.